{
    "startDate": "2020-04-01",
    "endDate": "2020-06-30",
    "year": "2020",
    "quarter": "Q2",
    "symbol": "LIFE",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents at beginning of period",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "unit": "usd",
                "value": 21632000
            },
            {
                "label": "Cash and cash equivalents at beginning of period",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "unit": "usd",
                "value": 21632000
            }
        ],
        "cf": [],
        "ic": [
            {
                "label": "Total revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 189000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 4361000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2146000
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 6507000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -6318000
            },
            {
                "label": "Total other expense, net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -129000
            },
            {
                "label": "Consolidated net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -6447000
            },
            {
                "label": "Net loss attributable to noncontrolling interest in Pangu BioPharma Limited",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Net loss attributable to aTyr Pharma, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -6446000
            },
            {
                "label": "Net loss per share, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.69
            },
            {
                "label": "Shares used in computing net loss per share, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 9357432
            }
        ]
    }
}